Zimmer Financial Statements From 2010 to 2024

ZBH Stock  USD 119.33  1.97  1.62%   
Zimmer Biomet financial statements provide useful quarterly and yearly information to potential Zimmer Biomet Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Zimmer Biomet financial statements helps investors assess Zimmer Biomet's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Zimmer Biomet's valuation are summarized below:
Gross Profit
4.9 B
Profit Margin
0.1385
Market Capitalization
24.5 B
Enterprise Value Revenue
4.2023
Revenue
7.4 B
We have found one hundred twenty available fundamental gauges for Zimmer Biomet Holdings, which can be analyzed and compared to other ratios and to its peers. Traders should compare all of Zimmer Biomet Holdings prevalent fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 12.2 B. Enterprise Value is estimated to decrease to about 12.5 B

Zimmer Biomet Total Revenue

4.96 Billion

Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer main balance sheet or income statement drivers, such as Depreciation And Amortization of 526 M, Interest Expense of 141.2 M or Selling General Administrative of 2 B, as well as many exotic indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0156 or PTB Ratio of 1.94. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
This module can also supplement Zimmer Biomet's financial leverage analysis and stock options assessment as well as various Zimmer Biomet Technical models . Check out the analysis of Zimmer Biomet Correlation against competitors.

Zimmer Biomet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding164.9 M209.7 M194 M
Slightly volatile
Total Assets13.7 B21.5 B18 B
Slightly volatile
Other Current Liabilities941.7 M1.3 B1.2 B
Slightly volatile
Total Current Liabilities1.5 B2.9 BB
Slightly volatile
Total Stockholder Equity7.4 B12.5 B9.1 B
Slightly volatile
Property Plant And Equipment Net1.4 B2.3 B1.6 B
Slightly volatile
Accounts Payable228.6 M379.8 M272.1 M
Slightly volatile
Non Current Assets Total10.3 B16.9 B13.9 B
Slightly volatile
Non Currrent Assets Other561.5 M559.1 M776.2 M
Slightly volatile
Net Receivables975.8 M1.4 B1.2 B
Slightly volatile
Liabilities And Stockholders Equity13.7 B21.5 B18 B
Slightly volatile
Non Current Liabilities Total4.8 B6.2 BB
Slightly volatile
Inventory1.4 B2.4 B1.7 B
Slightly volatile
Other Current Assets363.9 M366.1 M405.5 M
Slightly volatile
Total Liabilities6.3 BBB
Slightly volatile
Property Plant And Equipment Gross7.1 B6.8 B2.9 B
Slightly volatile
Total Current Assets3.4 B4.6 B4.2 B
Slightly volatile
Other Liabilities1.2 B1.3 B1.6 B
Pretty Stable
Other Assets1.4 B1.3 B717.7 M
Slightly volatile
Property Plant Equipment1.4 B2.2 B1.7 B
Slightly volatile
Short and Long Term Debt Total4.3 BB5.9 B
Slightly volatile
Net Debt3.7 B5.6 B5.2 B
Slightly volatile
Retained Earnings6.8 B10.4 B8.2 B
Slightly volatile
Cash591.2 M415.8 M678 M
Pretty Stable
Long Term DebtBB5.3 B
Slightly volatile
Cash And Short Term Investments732.9 M415.8 M862.8 M
Slightly volatile
Common Stock Total Equity2.9 M3.6 M2.9 M
Slightly volatile
Short Term Debt1.3 B952.9 M1.4 B
Very volatile
Common StockM3.2 M2.9 M
Slightly volatile
Good WillB8.8 B6.9 B
Slightly volatile
Intangible Assets4.2 B4.9 B4.9 B
Slightly volatile
Retained Earnings Total Equity9.1 B11 B8.7 B
Slightly volatile
Capital Surpluse7.5 B10.9 B7.2 B
Slightly volatile
Non Current Liabilities OtherB652.2 M963.4 M
Slightly volatile
Long Term Debt Total6.5 B5.9 B5.6 B
Slightly volatile
Long Term Investments73.1 M69.6 M37.2 M
Slightly volatile
Short and Long Term Debt1.5 B900 M1.4 B
Very volatile
Cash And Equivalents454.3 M338.1 M571.5 M
Slightly volatile
Net Invested Capital13 B18.4 B18.7 B
Slightly volatile
Net Working CapitalB1.8 B1.7 B
Slightly volatile
Capital Stock3.4 M3.2 M3.1 M
Slightly volatile

Zimmer Biomet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization526 M951.7 M734.3 M
Slightly volatile
Selling General AdministrativeB2.8 B2.5 B
Slightly volatile
Total RevenueB7.4 BB
Slightly volatile
Gross Profit3.6 B4.7 B4.2 B
Slightly volatile
Other Operating Expenses3.9 BB4.8 B
Slightly volatile
Operating Income857.6 M1.4 B826.3 M
Pretty Stable
EBIT1.1 B1.4 B1.1 B
Pretty Stable
Research Development259 M458.7 M311.1 M
Slightly volatile
EBITDA1.6 B2.3 B1.8 B
Slightly volatile
Cost Of Revenue1.4 B2.7 B1.7 B
Slightly volatile
Total Operating Expenses2.5 B3.3 B3.1 B
Slightly volatile
Selling And Marketing Expenses124.7 M181.5 M151.3 M
Slightly volatile
Non Recurring410.1 M336.7 M363.6 M
Pretty Stable
Interest Income148.5 M189.5 M177.3 M
Slightly volatile
Reconciled Depreciation808.5 M939 MB
Slightly volatile

Zimmer Biomet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow899.3 M892.4 MB
Slightly volatile
Begin Period Cash Flow602.2 M375.7 M737.7 M
Slightly volatile
Depreciation514 M951.7 M714.5 M
Slightly volatile
Capital Expenditures723.7 M689.2 M239.7 M
Slightly volatile
Total Cash From Operating Activities1.1 B1.6 B1.2 B
Slightly volatile
End Period Cash Flow596.1 M415.8 M720 M
Slightly volatile
Stock Based Compensation74.8 M99.8 M68.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.513.45143.5763
Very volatile
Dividend Yield0.01560.00790.0143
Slightly volatile
PTB Ratio1.942.04482.9559
Slightly volatile
Days Sales Outstanding55.2771.201270.6492
Slightly volatile
Book Value Per Share62.4959.51647.5226
Slightly volatile
Free Cash Flow Yield0.04080.0350.0541
Slightly volatile
Invested Capital0.670.46640.8824
Slightly volatile
Operating Cash Flow Per Share3.927.54226.2114
Slightly volatile
Stock Based Compensation To Revenue0.0130.01350.0113
Very volatile
PB Ratio1.942.04482.9559
Slightly volatile
EV To Sales4.924.2064.2656
Slightly volatile
Free Cash Flow Per Share3.224.25565.2006
Pretty Stable
ROIC0.06850.07210.0895
Slightly volatile
Inventory Turnover1.31.14511.1033
Slightly volatile
Days Of Inventory On Hand259319341
Slightly volatile
Payables Turnover4.97.19126.3317
Very volatile
Sales General And Administrative To Revenue0.450.520.4261
Slightly volatile
Research And Ddevelopement To Revenue0.04160.0620.0503
Slightly volatile
Cash Per Share2.781.98284.5728
Slightly volatile
POCF Ratio20.8516.135917.3496
Pretty Stable
Interest Coverage13.757.10199.8462
Slightly volatile
PFCF Ratio25.9628.597620.9065
Slightly volatile
Days Payables Outstanding69.3150.756861.2727
Pretty Stable
EV To Operating Cash Flow23.119.663621.3401
Pretty Stable
EV To Free Cash Flow28.8934.849725.965
Slightly volatile
Intangibles To Total Assets0.450.63610.5717
Slightly volatile
Net Debt To EBITDA1.342.38572.4893
Slightly volatile
Current Ratio2.851.61322.5749
Slightly volatile
Receivables Turnover5.95.12635.1827
Slightly volatile
Graham Number84.9180.864754.8162
Slightly volatile
Shareholders Equity Per Share62.4959.51647.5226
Slightly volatile
Debt To Equity0.670.46640.8824
Slightly volatile
Revenue Per Share17.4231.7329.7483
Slightly volatile
Interest Debt Per Share15.9228.689129.8627
Slightly volatile
Debt To Assets0.180.27080.3003
Very volatile
Enterprise Value Over EBITDA15.4213.297914.1708
Slightly volatile
Short Term Coverage Ratios1.581.6598131
Pretty Stable
Operating Cycle314390412
Pretty Stable
Price Book Value Ratio1.942.04482.9559
Slightly volatile
Days Of Payables Outstanding69.3150.756861.2727
Pretty Stable
Price To Operating Cash Flows Ratio20.8516.135917.3496
Pretty Stable
Price To Free Cash Flows Ratio25.9628.597620.9065
Slightly volatile
Operating Profit Margin0.220.18760.1573
Slightly volatile
Company Equity Multiplier2.281.72241.9447
Slightly volatile
Long Term Debt To Capitalization0.220.28060.3557
Pretty Stable
Total Debt To Capitalization0.230.31810.3799
Pretty Stable
Return On Capital Employed0.07070.07440.1007
Slightly volatile
Debt Equity Ratio0.670.46640.8824
Slightly volatile
Ebit Per Revenue0.220.18760.1573
Slightly volatile
Quick Ratio0.620.65031.2983
Slightly volatile
Net Income Per E B T0.810.95941.2462
Very volatile
Cash Ratio0.140.14550.4432
Slightly volatile
Cash Conversion Cycle263339352
Slightly volatile
Operating Cash Flow Sales Ratio0.250.21390.2136
Pretty Stable
Days Of Inventory Outstanding259319341
Slightly volatile
Days Of Sales Outstanding55.2771.201270.6492
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.650.56420.8296
Slightly volatile
Cash Flow Coverage Ratios0.260.27170.3323
Slightly volatile
Price To Book Ratio1.942.04482.9559
Slightly volatile
Fixed Asset Turnover4.943.26574.0248
Slightly volatile
Price Cash Flow Ratio20.8516.135917.3496
Pretty Stable
Enterprise Value Multiple15.4213.297914.1708
Slightly volatile
Debt Ratio0.180.27080.3003
Very volatile
Cash Flow To Debt Ratio0.260.27170.3323
Slightly volatile
Price Sales Ratio4.513.45143.5763
Very volatile
Asset Turnover0.680.3440.4617
Slightly volatile
Gross Profit Margin0.80.63060.7155
Very volatile
Price Fair Value1.942.04482.9559
Slightly volatile

Zimmer Biomet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.2 B14.6 B15.7 B
Slightly volatile
Enterprise Value12.5 B14.4 B15.6 B
Slightly volatile

Zimmer Fundamental Market Drivers

Forward Price Earnings15.5039
Cash And Short Term Investments415.8 M

Zimmer Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zimmer Biomet Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Zimmer Biomet income statement, its balance sheet, and the statement of cash flows. Zimmer Biomet investors use historical funamental indicators, such as Zimmer Biomet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet investors may use each financial statement separately, they are all related. The changes in Zimmer Biomet's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zimmer Biomet's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Zimmer Biomet Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Zimmer Biomet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue180 M189 M
Total Revenue7.4 BB
Cost Of Revenue2.7 B1.4 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.52  0.45 
Research And Ddevelopement To Revenue 0.06  0.04 
Capex To Revenue(0.09)(0.09)
Revenue Per Share 31.73  17.42 
Ebit Per Revenue 0.19  0.22 

Zimmer Biomet Investors Sentiment

The influence of Zimmer Biomet's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Zimmer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Zimmer Biomet's public news can be used to forecast risks associated with an investment in Zimmer. The trend in average sentiment can be used to explain how an investor holding Zimmer can time the market purely based on public headlines and social activities around Zimmer Biomet Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Zimmer Biomet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Zimmer Biomet's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Zimmer Biomet's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Zimmer Biomet.

Zimmer Biomet Implied Volatility

    
  31.67  
Zimmer Biomet's implied volatility exposes the market's sentiment of Zimmer Biomet Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Zimmer Biomet's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Zimmer Biomet stock will not fluctuate a lot when Zimmer Biomet's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zimmer Biomet in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zimmer Biomet's short interest history, or implied volatility extrapolated from Zimmer Biomet options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.16)
Dividend Share
0.96
Earnings Share
4.88
Revenue Per Share
35.43
Quarterly Revenue Growth
0.063
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.